Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · IEX Real-Time Price · USD
1.380
-0.070 (-4.83%)
Jul 22, 2024, 11:02 AM EDT - Market open
Artelo Biosciences Employees
Artelo Biosciences had 6 employees as of December 31, 2023. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,600,667
Market Cap
4.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| IM Cannabis | 95 |
| Sharps Technology | 57 |
| Intelligent Bio Solutions | 51 |
| Processa Pharmaceuticals | 13 |
| Adial Pharmaceuticals | 7 |
| Portage Biotech | 7 |
| Creative Medical Technology Holdings | 4 |
| Evoke Pharma | 4 |
ARTL News
- 7 days ago - Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor - GlobeNewsWire
- 19 days ago - Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium - GlobeNewsWire
- 6 weeks ago - Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society - GlobeNewsWire
- 7 weeks ago - Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24 - GlobeNewsWire
- 2 months ago - Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th - GlobeNewsWire
- 3 months ago - Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy - GlobeNewsWire
- 3 months ago - Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time - GlobeNewsWire